Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2012

01.01.2012 | Epidemiology

Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer

verfasst von: Tove F. Tvedskov, Maj-Britt Jensen, Niels Kroman, Eva Balslev

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Isolated tumor cells (ITC) are more common in the sentinel node (SN) after needle biopsy of a breast cancer, indicating iatrogenic displacement of tumor cells. We here investigate whether similar iatrogenic displacement occurs after surgical excision of a breast tumor. We compared the incidence of ITC in the SN of 414 breast cancer patients with recent surgical excision to a group of 16,960 patients without recent surgical procedure in a multivariate analysis by linking data from the Danish Breast Cancer Cooperative Group database and the Danish National Health Register. Moreover, the incidence of spread to non-SNs in patients with ITC in the SN after recent surgical excision was analyzed. We found an adjusted odds ratio on 3.73 (95% CI 2.57–5.43; P < 0.0001) for having ITC in the SN after surgical excision. The increase in ITC after surgical excision was especially seen in patients with ductal carcinomas (OR 4.66; 95% CI 3.03–7.19). None of the patients with ITC in SN after surgical excision had further spread to non-SNs compared to 12% in the group without recent surgical excision (P = 0.09). The nearly fourfold increase in ITC in the SN after surgical excision indicates that this procedure induces iatrogenic displacement of tumor cells. This displacement was more common in ductal carcinomas. We found no further dissemination to non-SNs in patients with ITC in the SN after recent surgical excision, and it is questioned whether these patients benefit from an axillary lymph node dissection.
Literatur
1.
Zurück zum Zitat Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384PubMedCrossRef Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384PubMedCrossRef
2.
Zurück zum Zitat Dowlatshahi K, Fan M, Snider HC, Habib FA (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197PubMedCrossRef Dowlatshahi K, Fan M, Snider HC, Habib FA (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197PubMedCrossRef
3.
Zurück zum Zitat Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM (2005) The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 31:500–505PubMedCrossRef Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM (2005) The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 31:500–505PubMedCrossRef
4.
Zurück zum Zitat Grabau D, Jensen MB, Rank F, Blichert-Toft M (2007) Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. APMIS 115:828–837PubMedCrossRef Grabau D, Jensen MB, Rank F, Blichert-Toft M (2007) Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. APMIS 115:828–837PubMedCrossRef
5.
Zurück zum Zitat Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683–689PubMedCrossRef Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683–689PubMedCrossRef
6.
Zurück zum Zitat van Deurzen CH, Bult P, de Boer M et al (2009) Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement? Am J Surg Pathol 33:106–110PubMedCrossRef van Deurzen CH, Bult P, de Boer M et al (2009) Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement? Am J Surg Pathol 33:106–110PubMedCrossRef
7.
Zurück zum Zitat van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heijnen VC, van Diest PJ (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574–1580PubMedCrossRef van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heijnen VC, van Diest PJ (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574–1580PubMedCrossRef
8.
Zurück zum Zitat Christiansen P, Friis E, Balslev E, Jensen D, Moller S (2008) Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol 47:561–568PubMedCrossRef Christiansen P, Friis E, Balslev E, Jensen D, Moller S (2008) Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol 47:561–568PubMedCrossRef
9.
Zurück zum Zitat Husen M, Paaschburg B, Flyger HL (2006) Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15:620–628PubMedCrossRef Husen M, Paaschburg B, Flyger HL (2006) Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15:620–628PubMedCrossRef
10.
Zurück zum Zitat Bleiweiss IJ, Nagi CS, Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24:2013–2018PubMedCrossRef Bleiweiss IJ, Nagi CS, Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24:2013–2018PubMedCrossRef
11.
Zurück zum Zitat Diaz NM, Cox CE, Ebert M et al (2004) Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 28:1641–1645PubMedCrossRef Diaz NM, Cox CE, Ebert M et al (2004) Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 28:1641–1645PubMedCrossRef
12.
Zurück zum Zitat Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HS III (2004) Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 100:929–934PubMedCrossRef Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HS III (2004) Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 100:929–934PubMedCrossRef
13.
Zurück zum Zitat Hansen NM, Ye X, Grube BJ, Giuliano AE (2004) Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 139:634–639PubMedCrossRef Hansen NM, Ye X, Grube BJ, Giuliano AE (2004) Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 139:634–639PubMedCrossRef
14.
Zurück zum Zitat Moller S, Jensen MB, Ejlertsen B et al (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47:506–524PubMedCrossRef Moller S, Jensen MB, Ejlertsen B et al (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47:506–524PubMedCrossRef
15.
Zurück zum Zitat Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef
16.
Zurück zum Zitat Rostgaard K, Holst H, Mouridsen HT, Lynge E (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11:669–674PubMedCrossRef Rostgaard K, Holst H, Mouridsen HT, Lynge E (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11:669–674PubMedCrossRef
17.
Zurück zum Zitat Jensen AR, Storm HH, Moller S, Overgaard J (2003) Validity and representativity in the Danish Breast Cancer Cooperative Group—a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol 42:179–185PubMedCrossRef Jensen AR, Storm HH, Moller S, Overgaard J (2003) Validity and representativity in the Danish Breast Cancer Cooperative Group—a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol 42:179–185PubMedCrossRef
18.
Zurück zum Zitat Nickelsen TN (2001) Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 164:33–37PubMed Nickelsen TN (2001) Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 164:33–37PubMed
19.
Zurück zum Zitat Kiaer HW, Laenkholm AV, Nielsen BB, Bjerre KD (2008) Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group’s register 1978–2006. Acta Oncol 47:778–783PubMedCrossRef Kiaer HW, Laenkholm AV, Nielsen BB, Bjerre KD (2008) Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group’s register 1978–2006. Acta Oncol 47:778–783PubMedCrossRef
20.
Zurück zum Zitat Straver ME, Meijnen P, van Tienhoven G et al (2010) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981–22023 AMAROS Trial. Ann Surg Oncol 17:1854–1861PubMedCrossRef Straver ME, Meijnen P, van Tienhoven G et al (2010) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981–22023 AMAROS Trial. Ann Surg Oncol 17:1854–1861PubMedCrossRef
21.
Zurück zum Zitat Carter BA, Jensen RA, Simpson JF, Page DL (2000) Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113:259–265PubMedCrossRef Carter BA, Jensen RA, Simpson JF, Page DL (2000) Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113:259–265PubMedCrossRef
22.
Zurück zum Zitat Mittendorf EA, Sahin AA, Tucker SL et al (2008) Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15:3369–3377PubMedCrossRef Mittendorf EA, Sahin AA, Tucker SL et al (2008) Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15:3369–3377PubMedCrossRef
23.
Zurück zum Zitat Vincent-Salomon A, Caly M, De RY et al (2009) Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma. Eur J Cancer 45:1979–1986PubMedCrossRef Vincent-Salomon A, Caly M, De RY et al (2009) Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma. Eur J Cancer 45:1979–1986PubMedCrossRef
24.
Zurück zum Zitat Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313PubMed Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313PubMed
Metadaten
Titel
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer
verfasst von
Tove F. Tvedskov
Maj-Britt Jensen
Niels Kroman
Eva Balslev
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1720-y

Weitere Artikel der Ausgabe 1/2012

Breast Cancer Research and Treatment 1/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.